SENS™
We develop innovative delivery
technologies that can be employed
for various gene therapeutics.
By enabling the delivery of nucleic acid drugs to desired tissues, SENS™ technology can be used to develop various therapeutics including vaccines.
| Indication | Technology | Project | Discovery | Preclinical | Clinical | Registration |
|---|---|---|---|---|---|---|
| Infectious Disease |
mRNA COVID vaccine |
SYP-2246 | ||||
| Infectious Disease |
mRNA HCV vaccine |
SYP-2583 | ||||
| Cancer | mRNA Cancer vaccine |
SYP-2135 | ||||
| Idiopathic pulmonary Fibrosis |
mRNA therapy | SYP-2590 | ||||
| TBD | Lung Delivery (endothelium) |
SYP-2137 | ||||
| TBD | Lung Delivery (epithelium) |
SYP-2137 | ||||
| TBD | Liver Delivery | SYP-2136 | ||||
| TBD | CNS Delivery | SYP-2566 |
